Evidence mapPaperPMID 41399666Full record

ReviewInternational journal of cardiology. Cardiovascular risk and prevention2025

Can we better prevent cardiovascular disease? 'Stayin' healthy to stay alive'.

Duncan J Campbell

Abstract readReview
In one paragraph

Review in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antioxidants (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Duncan J CampbellSt. Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) is a major contributor to premature morbidity and mortality. We have the tools to prevent CVD, but they are not being applied as effectively as they might. Key contributors to sub-optimal CVD risk factor control are the community's lack of awareness of CVD risk and individuals' lack of awareness of their own CVD risk and 'optimal' targets for risk factors. Additional contributors to sub-optimal CVD risk factor control include failure to treat, lack of adherence with therapy, and failure to achieve therapeutic targets. The Australian SunSmart program for preventing skin cancer by reducing sun exposure provides a potential template for a community-based education program, with support from nurses, pharmacists and allied health, that educates and empowers children and all members of the community to improve CVD risk management by increasing awareness and treatment of CVD risk, improving adherence with risk factor control strategies, and improving success in achievement of target outcomes for risk factors, thereby achieving life-long CVD risk factor control and CVD prevention.

Indexed as

Blood pressureCholesterolPrevention of cardiovascular disease

Identifiers

PMID41399666
PMCPMC12702022

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.